Carregant...
Casual effect of methotrexate+etanercept/infliximab on survival of patients with rheumatoid arthritis
Background and objectives: Following the discovery of new drugs, physicians and pharmaceutical companies have become interested in examining patients’ mortality and morbidity rates. In this respect, the effects of methotrexate (MTX)+etanercept/infliximab (ETA/INF) therapy on the survival of rheumato...
Guardat en:
| Publicat a: | Pragmat Obs Res |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503221/ https://ncbi.nlm.nih.gov/pubmed/31118865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/POR.S194408 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|